X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.74
Delayed Data
As of 3:59pm ET
 -0.0821 / -4.51%
Today’s Change
1.55
Today|||52-Week Range
4.14
-23.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
AssetsCash6.3M6.1M5.8M5.5M
 
 
 
 
 
Cash & Short Term Investments6.3M6.1M6.1M5.5M
 
 
 
 
 
 
ReceivablesReceivables----27.0K--
 
 
 
InventoriesInventories----0.000.00--
 
Current AssetsPrepaid Expenses----85.0K--
 
 
Other Current Assets466.6K358.6K0.00508.0K
 
 
 
 
Current Assets6.8M6.4M6.2M6.0M
 
 
 
 
 
 
Total AssetsIntangible Assets----380.0K--
 
 
Other Assets379.7K380.6K380.0K380.0K
 
 
 
 
 
Total Assets7.2M6.8M6.6M6.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable----4.0K--
 
 
Accrued Expenses----276.0K--
 
 
Other Current Liabilities381.7K285.7K276.0K232.0K
 
 
 
 
 
Other Liabilities381.7K285.7K300.0K232.0K
 
 
 
 
 
 
Total LiabilitiesOther Liabilities4.7M2.9M2.7M0.00
 
 
 
 
Total Liabilities5.1M3.2M3.0M232.0K
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock--0.000.000.00--
Common Equity2.1M3.6M3.6M6.2M
 
 
 
 
 
Total Shareholder Equity2.1M3.6M3.6M6.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding5.1M5.1M5.1M5.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.